Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach

Cytokine
S NajjamC C Rider

Abstract

We have developed an enzyme-linked immunosorbent assay (ELISA) approach for the study of interactions between cytokines and glycosaminoglycans. This involves, as solid phase, a synthetic heparin-bovine serum albumin (BSA) complex in which the heparin is coupled via its reducing terminus to the protein using sodium cyanoborohydride. We have investigated the sensitivity and specificity of this experimental technique, employing antithrombin (AT III) and fibroblast growth factor 2 (FGF-2) as well-characterized heparin binding proteins. Using this ELISA method, we have established that human recombinant interleukin (IL-2) binds to heparin in a concentration-dependent manner. Soluble heparin competes for the binding of IL-2 to the complex with 50% inhibition at 5 microg/ml. This IC50 value provides an estimate of the binding constant of around 0.5 microM. This value is at least two orders of magnitude larger than that for the binding of IL-2 to its dimeric and trimeric cell surface receptors, but similar to that for binding to the IL-2 receptor beta polypeptide acting alone. Our ELISA shows that in addition to soluble heparin, fuciodan also competes for IL-2 binding, but chondroitin sulfate and dermatan sulfate are inactive. Of six h...Continue Reading

Citations

Mar 31, 2005·Analytical Biochemistry·Warren C KettDeirdre R Coombe
Mar 24, 2004·Critical Reviews in Oncology/hematology·Yanusz Wegrowski, Francois-Xavier Maquart
Jun 1, 2005·Journal of Pharmaceutical and Biomedical Analysis·Aiye LiangBingcheng Lin
Jul 16, 2008·Immunology and Cell Biology·Deirdre R Coombe
Aug 10, 2011·Immunology and Cell Biology·Deirdre R Coombe
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Paul L BollykyGerald T Nepom
May 10, 2008·The Journal of Biological Chemistry·S M Khorshed AlamMichael J Soares
Feb 19, 2002·Journal of Immunoassay & Immunochemistry·Patrick SouliéJosé Courty
Dec 22, 2005·Infection and Immunity·Cheryl JenkinsSteven P Djordjevic
Jul 31, 2013·Molekuliarnaia biologiia·L NematollahiV Khalaj
Jan 8, 2011·Biological & Pharmaceutical Bulletin·Koji HigaiKojiro Matsumoto
Nov 10, 2013·PloS One·Federico TortelliJeffrey A Hubbell
Dec 24, 2005·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Takumi AkashiMasaki Yanagishita
Aug 25, 1999·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·A A KaleP E Di Cesare
Feb 19, 2013·Expert Review of Proteomics·Bernd GesslbauerAndreas J Kungl
Apr 26, 2005·FEBS Letters·Edwin C J M de VetR Duncan Campbell
Nov 17, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Peter Bradding, Greer Arthur
Sep 27, 2015·Journal of Molecular Graphics & Modelling·Jan-Philip Gehrcke, M Teresa Pisabarro
Sep 11, 2007·Biochemical and Biophysical Research Communications·Mohand-Ouidir OuidjaDulce Papy-Garcia
Jun 26, 2003·Cancer Science·Hitoshi KurokawaMasaki Yanagishita
Jun 21, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Mohamed AttiaIsabelle Martelly
Jun 9, 2004·Analytical Biochemistry·David J MahoneyRobert D Short
Jun 27, 2009·Biochemical and Biophysical Research Communications·Koji HigaiKojiro Matsumoto
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mark S SingerSteven D Rosen
Feb 5, 2008·Psychiatry Research·Benedicto Crespo-FacorroJosé Luis Vázquez-Barquero
Nov 27, 2007·Virus Research·Claudio PoiesiNino Manca
Oct 18, 2016·Molecular Genetics and Metabolism·Francyne KubaskiShunji Tomatsu
Aug 4, 2007·Glycobiology·Rosemary S MummeryChristopher C Rider
May 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Erik G HaymanJ Marc Simard
May 4, 2017·Blood·Carmen H CoxonYotis A Senis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.